BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32766130)

  • 21. Does Surgical Resection Significantly Prolong the Long-Term Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma? A Cross-Sectional Study Based on 18 Registries.
    Li Z; Zhang X; Sun C; Li Z; Fei H; Zhao D
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative radiotherapy does not improve and may even be detrimental to the long-term prognosis of patients diagnosed with stage III colon adenocarcinoma: a propensity score-matched SEER database analysis.
    Xu J; Niu X
    Front Oncol; 2023; 13():1324485. PubMed ID: 38074673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of radiotherapy in patients with resected ampullary carcinoma: findings based on the SEER database.
    Zhao W; Wang B; Zhao A; Tian Q; Zhang L; Wang L; Zhao X; Yang J; Dong D
    HPB (Oxford); 2019 Nov; 21(11):1535-1540. PubMed ID: 31056288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.
    McDade TP; Hill JS; Simons JP; Piperdi B; Ng SC; Zhou Z; Kadish SP; Fitzgerald TJ; Tseng JF
    Cancer; 2010 Jul; 116(13):3257-66. PubMed ID: 20564625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic mucinous adenocarcinoma has different clinical characteristics and better prognosis compared to non-specific PDAC: A retrospective observational study.
    Liu J; Zhang YJ; Zhou J; Zhang ZJ; Wen Y
    Heliyon; 2024 May; 10(9):e30268. PubMed ID: 38720717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.
    Pu N; Yin L; Habib JR; Gao S; Hu H; Zhu Y; Wu Y; Yu J; Lou W
    Future Oncol; 2019 Oct; 15(30):3457-3465. PubMed ID: 31460788
    [No Abstract]   [Full Text] [Related]  

  • 27. The benefit of adjuvant radiotherapy on overall survival in resected stage I to II pancreatic cancer: A propensity-adjusted analysis.
    Lin ZB; Song JY; Li AC; Chen C; Huang XX; Xu BH
    PLoS One; 2020; 15(12):e0243170. PubMed ID: 33315874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refining the American Joint Committee on Cancer Staging Scheme For Resectable Pancreatic Ductal Adenocarcinoma Using Recursive Partitioning Analysis.
    Jiang Y; Su Y; Chen Y; Li Z
    J Cancer; 2017; 8(14):2765-2773. PubMed ID: 28928865
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of Adjuvant Chemoradiotherapy on Survival of Resected Pancreatic Adenocarcinoma Cancer: A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Shi X; Peng J; Jiang H; Gao Y; Wang W; Zhou F
    Front Oncol; 2021; 11():651671. PubMed ID: 34277405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of adjuvant chemotherapy in stage I-III male breast cancer: a SEER-based analysis.
    Li WP; Gao HF; Ji F; Zhu T; Cheng MY; Yang M; Yang CQ; Zhang LL; Li JQ; Zhang JS; Wang K
    Ther Adv Med Oncol; 2020; 12():1758835920958358. PubMed ID: 33014148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival Benefit of Resection Surgery for Pancreatic Ductal Adenocarcinoma with Liver Metastases: A Propensity Score-Matched SEER Database Analysis.
    Pausch TM; Liu X; Cui J; Wei J; Miao Y; Heger U; Probst P; Heap S; Hackert T
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal adenocarcinoma patients with M1a diseases gain more clinical benefits from palliative primary tumor resection than those with M1b diseases: A propensity score matching analysis.
    Li CL; Tang DR; Ji J; Zang B; Chen C; Zhao JQ
    World J Clin Cases; 2020 Aug; 8(15):3230-3239. PubMed ID: 32874977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is There a Benefit to Adjuvant Chemotherapy in Resected, Early Stage Pancreatic Ductal Adenocarcinoma?
    Turner KM; Delman AM; Ammann AM; Sohal D; Olowokure O; Choe KA; Smith MT; Kharofa JR; Ahmad SA; Wilson GC; Patel SH
    Ann Surg Oncol; 2022 Mar; ():. PubMed ID: 35357614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population-based outcome of stage IA-IIA resected gastric adenocarcinoma: who should get adjuvant treatment?
    Gold JS; Al Natour RH; Saund MS; Yoon C; Sharma AM; Huang Q; Boosalis VA; Whang EE
    Ann Surg Oncol; 2013 Jul; 20(7):2304-10. PubMed ID: 23344580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival benefit of adjuvant chemotherapy in elderly patients with stage I triple-negative breast cancer: a cohort study based on the SEER database.
    Zhang Y; Liu X; Ma M; Chen C; Wang X
    Transl Cancer Res; 2023 Jul; 12(7):1741-1752. PubMed ID: 37588733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].
    Zhang Y; Wang X; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Sun Y; Ye D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):85-93. PubMed ID: 30703799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early-onset pancreatic cancer: a population-based study using the SEER registry.
    Ansari D; Althini C; Ohlsson H; Andersson R
    Langenbecks Arch Surg; 2019 Aug; 404(5):565-571. PubMed ID: 31377855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival benefit of local consolidative therapy for patients with single-organ metastatic pancreatic cancer: a propensity score-matched cross-sectional study based on 17 registries.
    Hu X; Hu D; Fu B; Li H; Ren G; Liu H; Song J; Kang X; Wang X; Pang H; Liu C; Zhang J; Wang Y
    Front Endocrinol (Lausanne); 2023; 14():1225979. PubMed ID: 38027134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Factors and Effect of Adjuvant Chemoradiation Following Chemotherapy in Resected Pancreatic Cancer Patients With Lymph Node Metastasis or R1 Resection.
    Xing J; Yang B; Hou X; Jia N; Gong X; Li X; Zhou N; Cheng Y; Bai C
    Front Oncol; 2021; 11():660215. PubMed ID: 34631515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.
    Waters JA; Schnelldorfer T; Aguilar-Saavedra JR; Chen JH; Yiannoutsos CT; Lillemoe KD; Farnell MB; Sarr MG; Schmidt CM
    J Am Coll Surg; 2011 Aug; 213(2):275-83. PubMed ID: 21601488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.